These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11922209)

  • 1. New bone-seeking agent: animal study of Tc-99m-incadronate.
    Shigematsu M; Shomi S; Iwao H; Ochi H
    Ann Nucl Med; 2002 Feb; 16(1):55-9. PubMed ID: 11922209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
    Abbasi IA
    Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V; Kumar D; Howman-Giles RB; Little DG
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans.
    Kemerink GJ; Boersma HH; Thimister PW; Hofstra L; Liem IH; Pakbiers MT; Janssen D; Reutelingsperger CP; Heidendal GA
    Eur J Nucl Med; 2001 Sep; 28(9):1373-8. PubMed ID: 11585297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
    Ogawa K; Mukai T; Inoue Y; Ono M; Saji H
    J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases.
    Lin WY; Lin CP; Yeh SJ; Hsieh BT; Tsai ZT; Ting G; Yen TC; Wang SJ; Knapp FF; Stabin MG
    Eur J Nucl Med; 1997 Jun; 24(6):590-5. PubMed ID: 9169563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of 99mTc-labeled interleukin-8 in experimental inflammation and infection.
    Rennen HJ; Boerman OC; Oyen WJ; Corstens FH
    J Nucl Med; 2003 Sep; 44(9):1502-9. PubMed ID: 12960199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological evaluation of 99mTc-labeled imidazolyl-containing diphosphonic acid as a novel bone imaging agent.
    Qiu L; Cheng W; Lin J; Zhang S; Luo S
    J Labelled Comp Radiopharm; 2013 Sep; 56(11):573-80. PubMed ID: 24285189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
    Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
    J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new bisphosphonate-containing (99m)Tc(I) tricarbonyl complex potentially useful as bone-seeking agent: synthesis and biological evaluation.
    Palma E; Oliveira BL; Correia JD; Gano L; Maria L; Santos IC; Santos I
    J Biol Inorg Chem; 2007 Jun; 12(5):667-79. PubMed ID: 17333301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V.
    Mochizuki T; Kuge Y; Zhao S; Tsukamoto E; Hosokawa M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
    J Nucl Med; 2003 Jan; 44(1):92-7. PubMed ID: 12515881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of lesion to normal bone uptake ratios of skeletal radiopharmaceuticals by QARG (quantitative autoradiography).
    Ghiron J; Volkert WA; Garlich J; Holmes RA
    Int J Rad Appl Instrum B; 1991; 18(2):235-40. PubMed ID: 2026500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rabbit biodistribution of a therapeutic dose of zoledronic acid labeled with Tc-99m.
    Asikoglu M; Durak FG
    Appl Radiat Isot; 2009 Sep; 67(9):1616-21. PubMed ID: 19457677
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Rashed HM; Marzook FA; Farag H
    Radiol Med; 2016 Dec; 121(12):935-943. PubMed ID: 27586132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel (99m)Tc-labeled diphosphonic acid as potential bone seeking agent: synthesis and biological evaluation.
    Qiu L; Cheng W; Lin J; Zhang S; Luo S
    Curr Radiopharm; 2013 Mar; 6(1):28-35. PubMed ID: 23256753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
    Blake GM; Moore AE; Fogelman I
    Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging.
    Suzuki K; Satake M; Suwada J; Oshikiri S; Ashino H; Dozono H; Hino A; Kasahara H; Minamizawa T
    Nucl Med Biol; 2011 Oct; 38(7):1011-8. PubMed ID: 21982572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new radiopharmaceutical for bone imaging: experimental study of 99mTc-HEDTMP].
    Hu S; Deng H; Jiang S; Luo S; Lei Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):811-5. PubMed ID: 20842850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases.
    Pauwels EK; Blom J; Camps JA; Hermans J; Rijke AM
    Eur J Nucl Med; 1983; 8(3):118-22. PubMed ID: 6220908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.